Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by fredgoodwinsonon Sep 30, 2021 5:57pm
288 Views
Post# 33948761

RE:RE:Volume picked up a bit

RE:RE:Volume picked up a bitHi Apophis - yes no stranger to manipulation here and this is likely some of the same but uncertainty can only thrive in a vacuum and as has been pointed out before some CEO`s of small caps commendably take on shorters and the like directly with their shareholders - something that in the moral vacuum that exists among the Politicians and Regulators can give significant comfort to retail shareholders with resultant beneficial effects on the sp and the ability to raise funds with minimal dilution. It may be no co-incidence that one of those where the CEO has acted in this way is no longer a small cap having left TLT in its`wake.

Beyond this there is surely a responsibility for a CEO to account at least minimally to the shareholders of a publicly-quoted Joint Stock Company.

Yes from memory the first Quarterly was issued less than a fortnight after the end of the relevant Quarter - Happy Days!




<< Previous
Bullboard Posts
Next >>